Rivastigmine solution in the one-year treatment of Parkinson’s disease dementia and dementia with Lewy bodies
Objective: Efficacy and safety of rivastigmine solution in the treatment of dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) is not well studied…Effect of Glucocerebrosidase enzymatic activity on neural activation during a cognitive task in Parkinson’s disease patients
Objective: To explore the potential correlation of blood Glucocerebrosidase (GCase) enzymatic activity with fMRI brain activity during Wisconsin Card Sorting Task (WCST), while assessing cognitive…Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)
Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model. Background: In PD, oxidative…Cerebellar tDCS modulates negative emotions recognition in Parkinson’s disease
Objective: To evaluate the role of the cerebellum in recognizing facial expressions in Parkinson's Disease (PD) patients. Background: PD is a neurodegenerative disorder characterized by…Amyloid deposition affects cognitive manifestations in Parkinson’s disease: The PPMI dataset
Objective: To investigate the contribution of amyloid depositions to cognitive deficits in the early phase of Parkinson’s disease (PD). Background: Involvement of amyloid deposits is…Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease
Objective: To examine the cerebral blood flow pattern of patients of Parkinson's disease with olfactory disorders, and to investigate the correlation between olfactory impairment and…Effective Tools for Mild Cognitive Impairment Level I Criteria of Movement Disorder Society: Utility of Screening Tests and Their Interconversion
Objective: Our primary aim was to test the utility of the universally accepted screening tests for detecting mild cognitive impairment (MCI) in patients with Parkinson’s…The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors
Objective: To investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson’s disease (PD) patients with mild cognitive impairment and to analyze relevant…The effects of sensory reward cues on risky decision making in Parkinson’s disease
Objective: To evaluate the effects of sensory reward cues on risky decision making in unmedicated and medicated Parkinson’s disease (PD). Background: Cue reactivity may play…Frontal midline theta activity is reduced during cognitive control in Parkinson’s disease
Objective: To investigate the role of frontal theta oscillation during cognitive control in Parkinson's disease (PD). Background: Mid-frontal theta activity underlies cognitive control. These 4-8…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.